Hepatitis is an inflammation of the liver caused by a variety of infectious viruses and non-infectious agents that causes a variety of health problems.
An estimated 354 million people worldwide suffer from hepatitis B or C, and for most, testing and treatment are beyond reach.
The new product called OraQuick HCV Self-Test, manufactured by US-based OraSure Technologies, is designed for use by anyone without any expertise.
WHO, in 2021, recommended HCV self-testing (HCVST) to complement existing HCV testing services in countries, and can help expand and further access to services, especially among those who may not otherwise get tested. can do.
"Viral hepatitis kills 3,500 people every day," said WHO's Dr. Meg Doherty. Of the 50 million people living with hepatitis C, only 36 percent had been diagnosed, and 20 percent could not be treated by the end of 2022. Treatment has been received." Director of the Global HIV, Hepatitis and STI Program Department.
He said, "Inclusion of this product on the WHO prequalification list provides a safe and effective way to expand HCV testing and treatment services, ensuring that more people receive the necessary diagnosis and treatment and ultimately HCV elimination." Can contribute to the global goal of. ,
Importantly, WHO says pre-qualified HCV self-testing will "help low- and middle-income countries gain access to safe and affordable self-testing options, diagnosing up to 90 percent of all people with HCV ", said Dr. Rogério Gaspar, WHO Director. Regulation and Pre-Qualification Department.
An estimated 354 million people worldwide suffer from hepatitis B or C, and for most, testing and treatment are beyond reach.
The new product called OraQuick HCV Self-Test, manufactured by US-based OraSure Technologies, is designed for use by anyone without any expertise.
WHO, in 2021, recommended HCV self-testing (HCVST) to complement existing HCV testing services in countries, and can help expand and further access to services, especially among those who may not otherwise get tested. can do.
"Viral hepatitis kills 3,500 people every day," said WHO's Dr. Meg Doherty. Of the 50 million people living with hepatitis C, only 36 percent had been diagnosed, and 20 percent could not be treated by the end of 2022. Treatment has been received." Director of the Global HIV, Hepatitis and STI Program Department.
He said, "Inclusion of this product on the WHO prequalification list provides a safe and effective way to expand HCV testing and treatment services, ensuring that more people receive the necessary diagnosis and treatment and ultimately HCV elimination." Can contribute to the global goal of. ,
Importantly, WHO says pre-qualified HCV self-testing will "help low- and middle-income countries gain access to safe and affordable self-testing options, diagnosing up to 90 percent of all people with HCV ", said Dr. Rogério Gaspar, WHO Director. Regulation and Pre-Qualification Department.